PL2468869T3 - Bakteryjna sekwencja wiodąca dla zwiększonej ekspresji - Google Patents
Bakteryjna sekwencja wiodąca dla zwiększonej ekspresjiInfo
- Publication number
- PL2468869T3 PL2468869T3 PL11194072T PL11194072T PL2468869T3 PL 2468869 T3 PL2468869 T3 PL 2468869T3 PL 11194072 T PL11194072 T PL 11194072T PL 11194072 T PL11194072 T PL 11194072T PL 2468869 T3 PL2468869 T3 PL 2468869T3
- Authority
- PL
- Poland
- Prior art keywords
- increased expression
- leader sequences
- bacterial leader
- bacterial
- sequences
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88747607P | 2007-01-31 | 2007-01-31 | |
| US88748607P | 2007-01-31 | 2007-01-31 | |
| EP08714119A EP2108047B1 (en) | 2007-01-31 | 2008-01-30 | Bacterial leader sequences for increased expression |
| EP11194072.2A EP2468869B1 (en) | 2007-01-31 | 2008-01-30 | Bacterial leader sequences for increased expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2468869T3 true PL2468869T3 (pl) | 2015-08-31 |
Family
ID=39462488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11194072T PL2468869T3 (pl) | 2007-01-31 | 2008-01-30 | Bakteryjna sekwencja wiodąca dla zwiększonej ekspresji |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7618799B2 (pl) |
| EP (2) | EP2468869B1 (pl) |
| JP (3) | JP5714230B2 (pl) |
| KR (1) | KR101491867B1 (pl) |
| CN (2) | CN102517280A (pl) |
| AU (1) | AU2008210538B2 (pl) |
| BR (1) | BRPI0807834A2 (pl) |
| CA (1) | CA2677179C (pl) |
| PL (1) | PL2468869T3 (pl) |
| WO (1) | WO2008094986A2 (pl) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| CA2546157C (en) * | 2003-11-21 | 2014-07-22 | Dow Global Technolgies Inc. | Improved expression systems with sec-system secretion |
| BRPI0513826A2 (pt) | 2004-07-26 | 2010-06-22 | Dow Global Technologies Inc | processo para expressão de proteìna melhorada através de engenharia de cepa |
| EP2468869B1 (en) * | 2007-01-31 | 2015-03-18 | Pfenex Inc. | Bacterial leader sequences for increased expression |
| US9394571B2 (en) | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| PL2419441T3 (pl) | 2009-04-17 | 2015-06-30 | Dow Agrosciences Llc | Owadzie toksyny Cry obejmujące DIG-3 |
| US7794969B1 (en) | 2009-07-09 | 2010-09-14 | Joule Unlimited, Inc. | Methods and compositions for the recombinant biosynthesis of n-alkanes |
| BR112012014801B1 (pt) | 2009-12-16 | 2024-03-05 | Dow Agrosciences Llc | Métodos para controlar o desenvolvimento da resistência de um inseto à uma proteína inseticida derivada de um bacillus thuringiensis, e para o controle de pragas de lepidópteros, bem como composição para o controle de pragas de lepidópteros |
| EP2542574B1 (en) | 2010-03-04 | 2017-08-09 | Pfenex Inc. | Method for producing soluble recombinant interferon protein without denaturing |
| KR20130072201A (ko) * | 2010-03-30 | 2013-07-01 | 피페넥스 인크. | 재조합 독소 단백질의 고수준 발현 |
| AU2010201410B2 (en) * | 2010-03-30 | 2015-04-30 | Pelican Technology Holdings, Inc. | High level expression of recombinant CRM197 |
| AU2011235210B2 (en) * | 2010-04-01 | 2015-07-16 | Pfenex Inc. | Methods for G-CSF production in a Pseudomonas host cell |
| NZ603561A (en) | 2010-04-23 | 2015-06-26 | Dow Agrosciences Llc | Combinations including cry34ab/35ab and cry3aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| US20120135486A1 (en) * | 2010-09-14 | 2012-05-31 | C/O Joule Unlimited Technologies, Inc. | Methods and Compositions for the Extracellular Transport of Biosynthetic Hydrocarbons and Other Molecules |
| GB201106225D0 (en) * | 2011-04-13 | 2011-05-25 | Glaxosmithkline Biolog Sa | Fermentation process |
| CN103648489A (zh) * | 2011-05-11 | 2014-03-19 | 儿童医疗中心有限公司 | 多抗原提呈免疫原性组合物及其方法和用途 |
| WO2013036861A1 (en) | 2011-09-08 | 2013-03-14 | Codexis, Inc | Biocatalysts and methods for the synthesis of substituted lactams |
| EP3459556A1 (en) | 2012-02-09 | 2019-03-27 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Synthetic analogs of lung surfactant protein sp-c and their use |
| ES3011307T3 (en) | 2012-02-23 | 2025-04-07 | Juno Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
| US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
| AR094276A1 (es) * | 2012-12-21 | 2015-07-22 | Alkem Laboratories Ltd | Marcadores de fusion y sistema de vector de expresion para la expresion de hormona paratiroides humana (rhpth) |
| US11576958B2 (en) | 2013-02-07 | 2023-02-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
| US9617573B2 (en) | 2013-02-28 | 2017-04-11 | Codexis, Inc. | Engineered transaminase polypeptides for industrial biocatalysis |
| PL2968470T3 (pl) | 2013-03-12 | 2021-05-31 | The General Hospital Corporation | Zmodyfikowane białka stanowiące substancję hamującą rozwój przewodów müllera (mis) i ich zastosowania do leczenia chorób |
| US9744223B2 (en) * | 2013-03-15 | 2017-08-29 | Panacea Pharmaceuticals, Inc. | Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase) |
| RU2013119826A (ru) | 2013-04-29 | 2014-11-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | Коринеформная бактерия и способ получения гетерологичных гибридных белков |
| ES2912283T3 (es) | 2013-12-11 | 2022-05-25 | Massachusetts Gen Hospital | Uso de proteínas de tipo sustancia inhibidora mülleriana (SIM) para la anticoncepción y conservación de la reserva ovárica |
| AU2015229035B2 (en) | 2014-03-14 | 2021-08-05 | Genentech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| TW201542093A (zh) | 2014-03-21 | 2015-11-16 | 艾格里遺傳學股份有限公司 | 用於控制玉米穗蟲之Ｃｒｙ１Ｄ |
| KR101660580B1 (ko) * | 2014-04-02 | 2016-09-28 | 프레스티지 바이오파마 피티이. 엘티디. | 항체의 당 함량 조절을 통한 항체의 제조 방법 |
| JP2017521055A (ja) | 2014-06-20 | 2017-08-03 | ダウ アグロサイエンシィズ エルエルシー | 害虫防除に有用な植物性殺虫タンパク質 |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| CN107532190B (zh) | 2014-12-01 | 2021-07-09 | 菲尼克斯公司 | 用于肽生产的融合伴侣 |
| CA3192494A1 (en) | 2014-12-30 | 2016-07-07 | Corteva Agriscience Llc | Modified cry1ca toxins useful for control of insect pests |
| DK3287523T3 (da) * | 2015-04-24 | 2022-07-25 | Ajinomoto Kk | Fremgangsmåde til sekretorisk fremstilling af protein |
| ES2846881T3 (es) | 2015-05-01 | 2021-07-30 | Inhibrx Inc | Moléculas que se dirigen al sistema de secreción de tipo III |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| EP3365453A2 (en) | 2015-10-22 | 2018-08-29 | Juno Therapeutics GmbH | Methods, kits, agents and apparatuses for transduction |
| MX2018004875A (es) | 2015-10-22 | 2018-08-01 | Juno Therapeutics Gmbh | Metodos para cultivar celulas y kits y aparatos para ello. |
| CN109154001B (zh) * | 2016-03-31 | 2023-07-18 | 埃泽瑞斯公司 | Utr序列 |
| WO2018063870A1 (en) | 2016-09-30 | 2018-04-05 | Dow Agrosciences Llc | Binary insecticidal cry toxins |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| BR112019012155A2 (pt) * | 2016-12-14 | 2019-11-12 | Wageningen Universiteit | uso de pelo menos uma molécula-guia de rna e uma proteína cas, método de ligação, clivagem, marcação ou modificação de um polinucleotídeo alvo de fita dupla, célula transformada, e, complexo de nucleoproteína |
| EA035353B1 (ru) * | 2017-02-28 | 2020-06-01 | Акционерное Общество "Биоамид" | Способ получения l-аспарагиновой кислоты и рекомбинантный штамм-продуцент аспартазы escherichia coli |
| AU2018243910B2 (en) | 2017-03-28 | 2025-04-10 | The Children's Medical Center Corporation | A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof |
| JP7339160B2 (ja) | 2017-04-27 | 2023-09-05 | ジュノ セラピューティクス ゲーエムベーハー | オリゴマー粒子試薬およびその使用方法 |
| MX2019015524A (es) | 2017-06-23 | 2020-09-10 | Univ Maryland | Composiciones inmunogenicas. |
| EP3701036A4 (en) * | 2017-10-27 | 2021-09-01 | Pfenex Inc. | PROCESS FOR PRODUCING ASPARAGINASE OF E. COLI |
| CA3077393A1 (en) | 2017-10-27 | 2019-05-02 | Pfenex Inc. | Bacterial leader sequences for periplasmic protein expression |
| JP7784804B2 (ja) * | 2017-10-27 | 2025-12-12 | フェネックス インク． | 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法 |
| CN111373033A (zh) * | 2017-11-23 | 2020-07-03 | 豪夫迈·罗氏有限公司 | 脯氨酸羟化酶及其相关用途、方法和产品 |
| KR101946789B1 (ko) * | 2018-01-26 | 2019-02-12 | (주)휴온스 | 이황화결합 이성질화효소 신호 펩타이드를 포함하는 재조합 벡터 및 이의 용도 |
| CN110655560A (zh) * | 2018-06-29 | 2020-01-07 | 复旦大学 | T7噬菌体尾部纤维蛋白多肽及其应用 |
| CN112969474A (zh) | 2018-09-12 | 2021-06-15 | 艾芬尼维克斯公司 | 多价肺炎球菌疫苗 |
| SG11202101973YA (en) | 2018-09-12 | 2021-03-30 | Childrens Medical Ct Corp | Pneumococcal fusion protein vaccines |
| SG11202104355SA (en) | 2018-10-31 | 2021-05-28 | Juno Therapeutics Gmbh | Methods for selection and stimulation of cells and apparatus for same |
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| EP3927733A4 (en) * | 2019-02-24 | 2022-07-06 | Oncosimis Biotech Private Limited | PROCESS FOR THE CONTINUOUS PRODUCTION OF RECOMBINANT GLP-1 PEPTIDE BY BACTERIA |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| WO2022211829A1 (en) | 2021-03-30 | 2022-10-06 | Jazz Pharmaceuticals Ireland Ltd. | Dosing of recombinant l-asparaginase |
| MX2024002779A (es) | 2021-09-09 | 2024-06-11 | Affinivax Inc | Vacunas neumocócicas multivalentes. |
| KR102527754B1 (ko) | 2022-07-07 | 2023-04-28 | 배성규 | 필터정화기능을 구비한 초기우수처리장치 |
| CN120349035B (zh) * | 2025-06-25 | 2025-11-11 | 上海明诺环境科技有限公司 | 一种聚甲醛废水处理方法及应用 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4551433A (en) | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
| US4595658A (en) | 1982-09-13 | 1986-06-17 | The Rockefeller University | Method for facilitating externalization of proteins synthesized in bacteria |
| US4511503A (en) | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4513600A (en) | 1983-01-03 | 1985-04-30 | The Minster Machine Company | Cam actuated ejector for a shell press |
| GB8308483D0 (en) | 1983-03-28 | 1983-05-05 | Health Lab Service Board | Secretion of gene products |
| US4755465A (en) | 1983-04-25 | 1988-07-05 | Genentech, Inc. | Secretion of correctly processed human growth hormone in E. coli and Pseudomonas |
| US4680264A (en) | 1983-07-01 | 1987-07-14 | Lubrizol Genetics, Inc. | Class II mobilizable gram-negative plasmid |
| US5281532A (en) | 1983-07-27 | 1994-01-25 | Mycogen Corporation | Pseudomas hosts transformed with bacillus endotoxin genes |
| US4637980A (en) | 1983-08-09 | 1987-01-20 | Smithkline Beckman Corporation | Externalization of products of bacteria |
| US5288852A (en) | 1984-03-06 | 1994-02-22 | Dainippon Pharmaceutical Co., Ltd. | Human tumor necrosis factor polypeptides |
| EP0155189A3 (en) | 1984-03-16 | 1987-09-16 | Genentech, Inc. | Expression of cell wall degrading proteins and host cells harboring dna encoding such protein |
| US4963495A (en) | 1984-10-05 | 1990-10-16 | Genentech, Inc. | Secretion of heterologous proteins |
| EP0177343B1 (en) | 1984-10-05 | 1992-07-22 | Genentech, Inc. | Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery |
| US4695455A (en) | 1985-01-22 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of pesticides produced by expression of heterologous genes |
| US4695462A (en) | 1985-06-28 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of biological pesticides |
| GB8517071D0 (en) | 1985-07-05 | 1985-08-14 | Hoffmann La Roche | Gram-positive expression control sequence |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| GB8529014D0 (en) | 1985-11-25 | 1986-01-02 | Biogen Nv | Enhanced secretion of heterologous proteins |
| US5232840A (en) | 1986-03-27 | 1993-08-03 | Monsanto Company | Enhanced protein production in bacteria by employing a novel ribosome binding site |
| EP0288451B1 (en) | 1987-04-23 | 1994-08-10 | Monsanto Company | Secretion of insulin-like growth factor 1 in E. coli |
| US5084384A (en) | 1987-04-23 | 1992-01-28 | Monsanto Company | Secretion of insulin-like growth factor-I |
| US5128130A (en) | 1988-01-22 | 1992-07-07 | Mycogen Corporation | Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens |
| US5055294A (en) | 1988-03-03 | 1991-10-08 | Mycogen Corporation | Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens |
| EP0422049A4 (en) | 1988-05-09 | 1991-11-13 | Us Health | Vector for secretion of proteins directly into periplasm or culture medium |
| US5169772A (en) | 1988-06-06 | 1992-12-08 | Massachusetts Institute Of Technology | Large scale method for purification of high purity heparinase from flavobacterium heparinum |
| US5175099A (en) | 1989-05-17 | 1992-12-29 | Research Corporation Technologies, Inc. | Retrovirus-mediated secretion of recombinant products |
| US5169760A (en) | 1989-07-27 | 1992-12-08 | Mycogen Corporation | Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters |
| CA2051400A1 (en) | 1989-12-15 | 1991-06-16 | Alan R. Browne | Autodeposition emulsion for selectively protecting metallic surfaces |
| US5641671A (en) | 1990-07-06 | 1997-06-24 | Unilever Patent Holdings B.V. | Production of active Pseudomonas glumae lipase in homologous or heterologous hosts |
| FI913434A7 (fi) | 1990-07-16 | 1992-01-17 | Technical Research Centre F Finland | Rekombinanta fusionsproteiner vilka utsoendras. |
| CA2052852A1 (en) | 1990-10-30 | 1992-05-01 | Carl Rande Shervin | Method of determining blend time in stirred tanks |
| JP3014434B2 (ja) | 1990-10-31 | 2000-02-28 | 昭和アルミニウム株式会社 | 熱交換器 |
| US5417971A (en) | 1991-10-22 | 1995-05-23 | University Of Saskatchewan | Vaccines for Actinobacillus pleuropneumoniae |
| US5348867A (en) | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
| JPH08510903A (ja) * | 1993-04-09 | 1996-11-19 | バイオ − テクノロジー・ジェネラル・コーポレーション | 蛭ヒルド・メディシナリスの組換えｘａ因子インヒビターの作製 |
| US5563046A (en) * | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US5914254A (en) | 1993-08-02 | 1999-06-22 | Celtrix Pharmaceuticals, Inc. | Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| US5527883A (en) | 1994-05-06 | 1996-06-18 | Mycogen Corporation | Delta-endotoxin expression in pseudomonas fluorescens |
| EP0797671B1 (en) | 1994-12-09 | 2004-03-03 | Novo Nordisk A/S | A process of producing extracellular proteins in bacteria |
| US6495357B1 (en) | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
| IT1283225B1 (it) | 1996-03-11 | 1998-04-16 | Renata Maria Anna Ve Cavaliere | Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle |
| US6361989B1 (en) | 1997-10-13 | 2002-03-26 | Novozymes A/S | α-amylase and α-amylase variants |
| US6156552A (en) | 1998-02-18 | 2000-12-05 | Novo Nordisk A/S | Lipase variants |
| US20030064435A1 (en) | 1998-05-28 | 2003-04-03 | Weiner Joel Hirsch | Compositions and methods for protein secretion |
| US6323007B1 (en) | 1998-09-18 | 2001-11-27 | Novozymes A/S | 2,6-β-D-fructan hydrolase enzyme and processes for using the enzyme |
| PT1124941E (pt) | 1998-10-28 | 2004-02-27 | Genentech Inc | Processo para recuperar polipeptidos heterologos a partir de celulas bacterianas |
| KR100312456B1 (ko) | 1999-03-13 | 2001-11-03 | 윤덕용 | 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자 |
| AU779814B2 (en) | 1999-03-29 | 2005-02-10 | Novozymes A/S | Polypeptides having branching enzyme activity and nucleic acids encoding same |
| US6664386B1 (en) | 1999-04-08 | 2003-12-16 | The Research Foundation Of State University Of New York | System for efficient secretion of recombinant proteins |
| US6558939B1 (en) | 1999-08-31 | 2003-05-06 | Novozymes, A/S | Proteases and variants thereof |
| DE19944870A1 (de) | 1999-09-18 | 2001-03-29 | Aventis Pharma Gmbh | Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium |
| FI107081B (fi) * | 1999-10-19 | 2001-05-31 | Abb Substation Automation Oy | Menetelmä ja järjestely osittaispurkauslähteiden lukumäärän selvittämiseksi |
| US6617143B1 (en) | 1999-10-20 | 2003-09-09 | Novozymes A/S | Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| US6509181B1 (en) | 2000-04-14 | 2003-01-21 | Novozymes, A/S | Polypeptides having haloperoxide activity |
| GB0027782D0 (en) | 2000-11-14 | 2000-12-27 | Boehringer Ingelheim Int | Methods fro large scale protein productio in prokaryotes |
| US7087412B2 (en) | 2000-11-14 | 2006-08-08 | Boehringer Ingelheim International Gmbh | Methods for large scale protein production in prokaryotes |
| US7202059B2 (en) | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
| DE10108212A1 (de) | 2001-02-20 | 2002-08-22 | Aventis Pharma Gmbh | Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände |
| US7419783B2 (en) | 2001-11-05 | 2008-09-02 | Research Development Foundation | Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| AU2002306484A1 (en) | 2002-02-13 | 2003-09-04 | Dow Global Technologies Inc. | Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| AU2003218217A1 (en) | 2002-03-15 | 2003-09-29 | The Trustees Of The University Of Pennsylvania | Heterologous protein production using the twin arginine translocation pathway |
| CA2482995C (en) | 2002-04-22 | 2013-01-29 | Dow Global Technologies Inc. | Low-cost production of peptides |
| EP1539794B1 (en) | 2002-07-03 | 2008-12-31 | Dow Global Technologies Inc. | Benzoate- and anthranilate-inducible promoters |
| CA2546157C (en) * | 2003-11-21 | 2014-07-22 | Dow Global Technolgies Inc. | Improved expression systems with sec-system secretion |
| EP1709170B1 (en) | 2004-01-16 | 2018-02-21 | Pfenex Inc. | Expression of mammalian proteins in pseudomonas fluorescens |
| BRPI0613593A2 (pt) * | 2005-07-08 | 2011-01-18 | Univ Zuerich | método de teste "phage display" filamentoso, vetor de fago ou de fagomìdeo e biblioteca de vetores de fago ou fagomìdeo |
| EP2021489A2 (en) * | 2006-05-30 | 2009-02-11 | Dow Global Technologies Inc. | Codon optimization method |
| EP2468869B1 (en) | 2007-01-31 | 2015-03-18 | Pfenex Inc. | Bacterial leader sequences for increased expression |
| US9394571B2 (en) * | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
-
2008
- 2008-01-30 EP EP11194072.2A patent/EP2468869B1/en active Active
- 2008-01-30 BR BRPI0807834-3A patent/BRPI0807834A2/pt not_active IP Right Cessation
- 2008-01-30 CA CA2677179A patent/CA2677179C/en active Active
- 2008-01-30 CN CN2011103821798A patent/CN102517280A/zh active Pending
- 2008-01-30 PL PL11194072T patent/PL2468869T3/pl unknown
- 2008-01-30 KR KR1020097017960A patent/KR101491867B1/ko active Active
- 2008-01-30 WO PCT/US2008/052434 patent/WO2008094986A2/en not_active Ceased
- 2008-01-30 EP EP08714119A patent/EP2108047B1/en active Active
- 2008-01-30 JP JP2009548414A patent/JP5714230B2/ja not_active Expired - Fee Related
- 2008-01-30 US US12/022,789 patent/US7618799B2/en active Active
- 2008-01-30 CN CN200880009677A patent/CN101641441A/zh active Pending
- 2008-01-30 AU AU2008210538A patent/AU2008210538B2/en active Active
-
2009
- 2009-10-22 US US12/604,061 patent/US7833752B2/en active Active
-
2010
- 2010-09-16 US US12/884,095 patent/US20110020868A1/en not_active Abandoned
-
2015
- 2015-03-11 JP JP2015047870A patent/JP6495690B2/ja active Active
-
2018
- 2018-02-19 JP JP2018027221A patent/JP2018102305A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2677179C (en) | 2016-02-16 |
| WO2008094986A8 (en) | 2009-07-30 |
| JP2018102305A (ja) | 2018-07-05 |
| JP2015144608A (ja) | 2015-08-13 |
| CN102517280A (zh) | 2012-06-27 |
| KR101491867B1 (ko) | 2015-02-10 |
| EP2108047B1 (en) | 2012-10-24 |
| CN101641441A (zh) | 2010-02-03 |
| JP2010517532A (ja) | 2010-05-27 |
| US20080193974A1 (en) | 2008-08-14 |
| WO2008094986A3 (en) | 2008-11-20 |
| AU2008210538A1 (en) | 2008-08-07 |
| EP2468869A1 (en) | 2012-06-27 |
| BRPI0807834A2 (pt) | 2014-07-22 |
| KR20090114422A (ko) | 2009-11-03 |
| JP6495690B2 (ja) | 2019-04-03 |
| AU2008210538B2 (en) | 2013-06-06 |
| US7618799B2 (en) | 2009-11-17 |
| EP2468869B1 (en) | 2015-03-18 |
| WO2008094986A2 (en) | 2008-08-07 |
| US7833752B2 (en) | 2010-11-16 |
| CA2677179A1 (en) | 2008-08-07 |
| US20110020868A1 (en) | 2011-01-27 |
| JP5714230B2 (ja) | 2015-05-07 |
| US20100048864A1 (en) | 2010-02-25 |
| EP2108047A2 (en) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2468869T3 (pl) | Bakteryjna sekwencja wiodąca dla zwiększonej ekspresji | |
| GB2448892B (en) | Catheter | |
| EP2257678A4 (en) | CHANNEL | |
| EP2164407A4 (en) | IMPROVED CATHETER | |
| KR101949907B9 (ko) | 유체-밸런싱 카세트 | |
| ZA200904015B (en) | Toothbrushes | |
| DK200800103A (en) | Integreret føringskant for vindturbineblad | |
| PL2136672T3 (pl) | Szczoteczka do zębów | |
| PL2318511T3 (pl) | Kompozycja bakteryjna | |
| AP3369A (en) | Function-based habitat design method | |
| EP2144496A4 (en) | IMPROVED AQUACULTURE SYSTEM | |
| GB0801640D0 (en) | Toothbrush | |
| GB0717315D0 (en) | Cassette | |
| GB0725147D0 (en) | Channel estimation | |
| EP2195319A4 (en) | POLYMORPHS OF VALOMACICLOVIR | |
| GB0610142D0 (en) | Channel estimation | |
| GB0701694D0 (en) | Fishing scope | |
| GB0718966D0 (en) | Bacterial vaccine | |
| GB0818317D0 (en) | Fishign reel | |
| GB0822725D0 (en) | Channel | |
| GB0703853D0 (en) | Toothbrush | |
| GB0808017D0 (en) | shRHA sequences | |
| GB0715878D0 (en) | Ward scheme | |
| AU313883S (en) | Reel | |
| GB0705811D0 (en) | S t e p |